CCL4 (Gene)

Organism:

Homo sapiens

Synonyms:ACT2, AT744.1, C-C motif chemokine ligand 4, CCL4, ENTREZ:6351, G-26, HC21, HGNC:10630, LAG-1, LAG1, MIM:182284, MIP-1-beta, MIP1B, MIP1B1, NM_002984, NP_002975, SCYA2, SCYA4

Omim:OMIM:182284

Id:1692c920-9090-575c-ab0b-0438c4c92f3e

Hgnc:HGNC:10630

Entrez:6351

Ensembl:ENSG00000275302

Description:C-C motif chemokine ligand 4

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CCL4's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CCL4.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CCL4.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CCL4.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CCL4.

Results found

Linked to

	Label	Description
	GSE137325 copanlisib Hair-M 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE191005 ENL knockout MOLM-13 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE234637 cytarabine 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE245677 CDK2 inhibition 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE137325 2 V 0 COPANLISIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE171837 bortezomib 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135030 11 V 6 FLUDARABINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE213291 GSE213294 GSK-J4 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE137325 copanlisib Hair-M 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE191005 ENL knockout MOLM-13 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE234637 cytarabine 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE245677 CDK2 inhibition 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE137325 2 V 0 COPANLISIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE171837 bortezomib 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE225901 dexamethasone 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE135030 11 V 6 FLUDARABINE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE213291 GSE213294 GSK-J4 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.